KYOKO STERNS: Open Payments
NPI 1336813930 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 27 payments from 9 companies in 2025. Trend: 2023 $817 · 2024 $743 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $178 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| SCPHARMACEUTICALS INC. | 2 | $50 |
| BridgeBio Pharma, Inc. | 2 | $50 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $38 |
| ABIOMED | 1 | $24 |
| PFIZER INC. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: JARDIANCE, VERQUVO, FUROSCIX, Attruby, LifeVest, ELIQUIS, LEQVIO, Kerendia.
Industry payments across NE — which companies pay providers there.
